版本:
中国

BRIEF-Nuvo Pharmaceuticals enters into license agreement with Sayre Therapeutics

March 28 Nuvo Pharmaceuticals Inc:

* Nuvo Pharmaceuticals™ enters into pennsaid® 2 pct license agreement with Sayre Therapeutics Pvt Ltd. For India, Sri Lanka, Bangladesh and Nepal

* Nuvo Pharmaceuticals Inc - has received an upfront payment and is eligible to receive milestone payments and a double-digit royalty on net sales

* Says Nuvo will supply pennsaid 2 pct to sayre on an exclusive basis from its manufacturing facility in varennes, québec

* Nuvo Pharmaceuticals Inc - agreement to distribute, market and sell pennsaid 2 pct in India, Sri Lanka, Bangladesh and Nepal ( territory)

* Nuvo Pharmaceuticals Inc - expect to complete pennsaid 2 pct out-licensing agreements for other territories throughout 2017 and 2018 Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐